Effect of Vision Centers on Access to Eye Care and Eye Health Outcomes
A Cluster-Randomized Trial Evaluating the Effect of Vision Centers on Access to Eye Care and Eye Health Outcomes in South Asia
1 other identifier
interventional
40,000
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the effect of vision centers on access to eye care and eye health outcomes in South Asia. The main questions it aims to answer are:
- 1.Do vision centers increase visits to eyecare centers?
- 2.Do vision centers increase spectacle ownership and wearing?
- 3.Do vision centers improve visual acuity of the population?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2025
CompletedFirst Posted
Study publicly available on registry
November 13, 2025
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
December 4, 2025
November 1, 2025
2.3 years
November 10, 2025
November 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of eyecare visits
The primary outcome is the prevalence of eyecare visits completed in the past one year, defined for each cluster as the number of individuals having completed at least one visit in the past year divided by the total number of individuals surveyed.
1 year
Secondary Outcomes (17)
Total number of visits to any eyecare provider
1 year
Prevalence of current spectacle ownership
2 years.
Effective refractive error coverage
2 years
Prevalence of spectacle wearing
2 years
Mean presenting and pinhole visual acuity
2 years
- +12 more secondary outcomes
Study Arms (2)
Immediate establishment of a vision center
EXPERIMENTALThe intervention arm will include the establishment of a fixed vision center equipped with trained vision technicians to provide basic eye care services and referrals to higher care.
Delayed establishment of a vision center
NO INTERVENTIONThe control arm will receive no intervention during the study period. The establishment of a vision center will occur after endline data collection, if hospital interest and resources remain adequate.
Interventions
The establishment of a vision center includes building a fixed center, and equipping it with a trained vision technician to provide basic eye care services such as refractive error correction, spectacle dispensing, basic diagnosis for common conditions, as well as referrals for advanced care at base hospitals. The establishment of VCs will be actively publicized in the neighboring communities through promotion by local stakeholders, teachers, community workers, village leaders, health workers, and radio announcements prior to establishment. Additional outreach activities include posters and loudspeaker announcements in the communities the day before operations begin.
Eligibility Criteria
You may qualify if:
- The catchment area of the proposed VC site is predominantly rural.
- The proposed VC site is located within 20-100 km of the base hospital.
- There are no major primary eye care services within 10 km of the proposed site.
- Care at sites randomized to establish VCs immediately is accessible to anyone.
You may not qualify if:
- Sites located in non-rural or urban catchment areas.
- Sites outside the 20-100 km distance range from the base hospital.
- Sites with existing major primary eye care services within a 10 km radius.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Franciscolead
- Seva Foundationcollaborator
- Proctor Foundationcollaborator
Study Sites (1)
University of California, San Francisco
San Francisco, California, 94158, United States
Related Publications (8)
Khanna RC, Sabherwal S, Sil A, Gowth M, Dole K, Kuyyadiyil S, Chase H. Primary eye care in India - The vision center model. Indian J Ophthalmol. 2020 Feb;68(2):333-339. doi: 10.4103/ijo.IJO_118_19.
PMID: 31957722BACKGROUNDRao GN, Khanna RC, Athota SM, Rajshekar V, Rani PK. Integrated model of primary and secondary eye care for underserved rural areas: the L V Prasad Eye Institute experience. Indian J Ophthalmol. 2012 Sep-Oct;60(5):396-400. doi: 10.4103/0301-4738.100533.
PMID: 22944748BACKGROUNDMisra V, Vashist P, Malhotra S, Gupta SK. Models for primary eye care services in India. Indian J Community Med. 2015 Apr-Jun;40(2):79-84. doi: 10.4103/0970-0218.153868.
PMID: 25861167BACKGROUNDVision Loss Expert Group of the Global Burden of Disease Study; GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020. Eye (Lond). 2024 Aug;38(11):2156-2172. doi: 10.1038/s41433-024-02961-1.
PMID: 38461217BACKGROUNDVision Loss Expert Group of the Global Burden of Disease Study; GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020. Eye (Lond). 2024 Aug;38(11):2083-2101. doi: 10.1038/s41433-024-03106-0. Epub 2024 Jul 4.
PMID: 38965322BACKGROUNDGBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021 Feb;9(2):e130-e143. doi: 10.1016/S2214-109X(20)30425-3. Epub 2020 Dec 1.
PMID: 33275950BACKGROUNDGBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
PMID: 33275949BACKGROUNDBurton MJ, Ramke J, Marques AP, Bourne RRA, Congdon N, Jones I, Ah Tong BAM, Arunga S, Bachani D, Bascaran C, Bastawrous A, Blanchet K, Braithwaite T, Buchan JC, Cairns J, Cama A, Chagunda M, Chuluunkhuu C, Cooper A, Crofts-Lawrence J, Dean WH, Denniston AK, Ehrlich JR, Emerson PM, Evans JR, Frick KD, Friedman DS, Furtado JM, Gichangi MM, Gichuhi S, Gilbert SS, Gurung R, Habtamu E, Holland P, Jonas JB, Keane PA, Keay L, Khanna RC, Khaw PT, Kuper H, Kyari F, Lansingh VC, Mactaggart I, Mafwiri MM, Mathenge W, McCormick I, Morjaria P, Mowatt L, Muirhead D, Murthy GVS, Mwangi N, Patel DB, Peto T, Qureshi BM, Salomao SR, Sarah V, Shilio BR, Solomon AW, Swenor BK, Taylor HR, Wang N, Webson A, West SK, Wong TY, Wormald R, Yasmin S, Yusufu M, Silva JC, Resnikoff S, Ravilla T, Gilbert CE, Foster A, Faal HB. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Glob Health. 2021 Apr;9(4):e489-e551. doi: 10.1016/S2214-109X(20)30488-5. Epub 2021 Feb 16. No abstract available.
PMID: 33607016BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Kieran O'Brien, PhD, MPH
University of California, San Francisco
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Survey data collectors and data analysts conducting the primary analyses will be masked. This will be achieved by not informing survey data collectors of arm assignment and by having an unmasked team member conceal arm assignment before primary analyses.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 10, 2025
First Posted
November 13, 2025
Study Start
March 1, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
December 4, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Within 6 months after the study ends.
- Access Criteria
- General public
De-identified cluster-level data will be shared publicly via osf.io